These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20642456)

  • 21. Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments.
    Aatkar A; Vuorinen A; Longfield OE; Gilbert K; Peltier-Heap R; Wagner CD; Zappacosta F; Rittinger K; Chung CW; House D; Tomkinson NCO; Bush JT
    ACS Chem Biol; 2023 Sep; 18(9):1926-1937. PubMed ID: 37084287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of β-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation.
    Hegedüs Z; Hóbor F; Shoemark DK; Celis S; Lian LY; Trinh CH; Sessions RB; Edwards TA; Wilson AJ
    Chem Sci; 2021 Jan; 12(6):2286-2293. PubMed ID: 34163995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A colorimetric assay adapted to fragment screening revealing aurones and chalcones as new arginase inhibitors.
    Muller J; Marchisio L; Attia R; Zedet A; Maradan R; Vallet M; Aebischer A; Harakat D; Senejoux F; Ramseyer C; Foley S; Cardey B; Girard C; Pudlo M
    RSC Med Chem; 2024 May; 15(5):1722-1730. PubMed ID: 38784454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor.
    Tamanini E; Miyamura S; Buck IM; Cons BD; Dawson L; East C; Futamura T; Goto S; Griffiths-Jones C; Hashimoto T; Heightman TD; Ishikawa S; Ito H; Kaneko Y; Kawato T; Kondo K; Kurihara N; McCarthy JM; Mori Y; Nagase T; Nakaishi Y; Reeks J; Sato A; Schöpf P; Tai K; Tamai T; Tisi D; Woolford AJ
    ACS Med Chem Lett; 2022 Oct; 13(10):1591-1597. PubMed ID: 36262388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping protein binding sites by photoreactive fragment pharmacophores.
    Ábrányi-Balogh P; Bajusz D; Orgován Z; Keeley AB; Petri L; Péczka N; Szalai TV; Pálfy G; Gadanecz M; Grant EK; Imre T; Takács T; Ranđelović I; Baranyi M; Marton A; Schlosser G; Ashraf QF; de Araujo ED; Karancsi T; Buday L; Tóvári J; Perczel A; Bush JT; Keserű GM
    Commun Chem; 2024 Jul; 7(1):168. PubMed ID: 39085342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting imidazole-glycerol phosphate dehydratase in plants: novel approach for structural and functional studies, and inhibitor blueprinting.
    Witek W; Sliwiak J; Rawski M; Ruszkowski M
    Front Plant Sci; 2024; 15():1343980. PubMed ID: 38559763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplexed Native Mass Spectrometry Determination of Ligand Selectivity for Fatty Acid-Binding Proteins.
    Phan MQ; Chandrashekaran IR; Akhtar N; Konstantinidou E; Devine SM; Doak BC; Nebl T; Creek DJ; Scanlon MJ; Norton RS
    ACS Med Chem Lett; 2024 Jul; 15(7):1071-1079. PubMed ID: 39015264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting a challenging p53 binding site: a diversity-optimized HEFLib reveals diverse binding modes in T-p53C-Y220C.
    Stahlecker J; Klett T; Schwer M; Jaag S; Dammann M; Ernst LN; Braun MB; Zimmermann MO; Kramer M; Lämmerhofer M; Stehle T; Coles M; Boeckler FM
    RSC Med Chem; 2022 Dec; 13(12):1575-1586. PubMed ID: 36561072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergent synthetic methods for the modular advancement of sp
    Caplin MJ; Foley DJ
    Chem Sci; 2021 Mar; 12(13):4646-4660. PubMed ID: 34168751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine
    Lu J; Bart AG; Wu Q; Criscione KR; McLeish MJ; Scott EE; Grunewald GL
    J Med Chem; 2020 Nov; 63(22):13878-13898. PubMed ID: 33147410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.
    Di Pisa F; Landi G; Dello Iacono L; Pozzi C; Borsari C; Ferrari S; Santucci M; Santarem N; Cordeiro-da-Silva A; Moraes CB; Alcantara LM; Fontana V; Freitas-Junior LH; Gul S; Kuzikov M; Behrens B; Pöhner I; Wade RC; Costi MP; Mangani S
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28282886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Native Mass Spectrometry in Fragment-Based Drug Discovery.
    Pedro L; Quinn RJ
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structures of endothiapepsin-fragment complexes from crystallographic fragment screening using a novel, diverse and affordable 96-compound fragment library.
    Huschmann FU; Linnik J; Sparta K; Ühlein M; Wang X; Metz A; Schiebel J; Heine A; Klebe G; Weiss MS; Mueller U
    Acta Crystallogr F Struct Biol Commun; 2016 May; 72(Pt 5):346-55. PubMed ID: 27139825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A ligand-observed mass spectrometry approach integrated into the fragment based lead discovery pipeline.
    Chen X; Qin S; Chen S; Li J; Li L; Wang Z; Wang Q; Lin J; Yang C; Shui W
    Sci Rep; 2015 Feb; 5():8361. PubMed ID: 25666181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design.
    Fjellström O; Akkaya S; Beisel HG; Eriksson PO; Erixon K; Gustafsson D; Jurva U; Kang D; Karis D; Knecht W; Nerme V; Nilsson I; Olsson T; Redzic A; Roth R; Sandmark J; Tigerström A; Öster L
    PLoS One; 2015; 10(1):e0113705. PubMed ID: 25629509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Missing fragments: detecting cooperative binding in fragment-based drug design.
    Nair PC; Malde AK; Drinkwater N; Mark AE
    ACS Med Chem Lett; 2012 Apr; 3(4):322-6. PubMed ID: 24900472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hitting the target: fragment screening with acoustic in situ co-crystallization of proteins plus fragment libraries on pin-mounted data-collection micromeshes.
    Yin X; Scalia A; Leroy L; Cuttitta CM; Polizzo GM; Ericson DL; Roessler CG; Campos O; Ma MY; Agarwal R; Jackimowicz R; Allaire M; Orville AM; Sweet RM; Soares AS
    Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1177-89. PubMed ID: 24816088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR-based approaches for the identification and optimization of inhibitors of protein-protein interactions.
    Barile E; Pellecchia M
    Chem Rev; 2014 May; 114(9):4749-63. PubMed ID: 24712885
    [No Abstract]   [Full Text] [Related]  

  • 39. Fragment-based screening by protein crystallography: successes and pitfalls.
    Chilingaryan Z; Yin Z; Oakley AJ
    Int J Mol Sci; 2012 Oct; 13(10):12857-79. PubMed ID: 23202926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal packing modifies ligand binding affinity: the case of aldose reductase.
    Cousido-Siah A; Petrova T; Hazemann I; Mitschler A; Ruiz FX; Howard E; Ginell S; Atmanene C; Van Dorsselaer A; Sanglier-Cianférani S; Joachimiak A; Podjarny A
    Proteins; 2012 Nov; 80(11):2552-61. PubMed ID: 22752989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.